Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News ABBOTT LABORATORIES ABT

Healthcare Medical Devices

Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the... see more

Add To Watchlist

Recent & Breaking News (NYSE:ABT)

New Canadian Report Shows Positivity Instead of Criticism is Key in Diabetes Management

Canada NewsWire October 30, 2024

Abbott Initiates New Clinical Trial to Improve Outcomes in Patients with Advanced Heart Failure

PR Newswire October 24, 2024

Abbott and the Big Ten Conference Tackle U.S. Blood Shortages With First-of-Its-Kind, Nationwide Blood Donation Competition, 'The We Give Blood Drive'

Accesswire October 23, 2024

Helping People Recover From Devastating Hurricanes

Accesswire October 21, 2024

Abbott Reports Third-Quarter 2024 Results and Raises Midpoint of Full-Year EPS Guidance Range

PR Newswire October 16, 2024

Abbott Advances Pulsed Field Ablation Clinical Studies and Launches New Technology to Support Advanced Cardiac Mapping

PR Newswire October 10, 2024

Abbott and the Big Ten Conference Tackle U.S. Blood Shortages with First-of-its-Kind, Nationwide Blood Donation Competition, 'The We Give Blood Drive'

PR Newswire September 26, 2024

Abbott Hosts Conference Call for Third-Quarter Earnings

PR Newswire September 25, 2024

Abbott Declares 403rd Consecutive Quarterly Dividend

PR Newswire September 19, 2024

Putting Health at the Center of Sustainability: Abbott Reports on Progress in Expanding Health Access, Broader 2030 Plan Performance

Accesswire September 12, 2024

Abbott's Lingo(TM) Continuous Glucose Monitor for Health and Wellness Now Available in the U.S.

PR Newswire September 5, 2024

Abbott Initiates Clinical Study to Evaluate the Use of Its Deep Brain Stimulation System to Manage Severe Depression

PR Newswire September 4, 2024

Abbott Expands its Pure Bliss(TM) Line of Infant Formulas to Include European-Made and Organic Products; Offers the First and Only Organic Liquid Formula Available at U.S. Retail Stores

PR Newswire August 27, 2024

Abbott's AVEIR(TM) DR - World's First Dual Chamber Leadless Pacemaker System - Now Available in Canada

Canada NewsWire August 15, 2024

Abbott Scholars Ready To Join the Fight Against Diabetes

Accesswire August 9, 2024

Quebec Expands Public Reimbursement of Abbott's FreeStyle Libre® 2 Flash Glucose Monitoring System to More Adults with Diabetes

Canada NewsWire August 8, 2024

What Happens When Communities Unite To Fight Diabetes?

Accesswire August 7, 2024

Abbott Enters Global Partnership to Connect Its World-Leading Continuous Glucose Monitoring System with Medtronic's Insulin Delivery Devices

PR Newswire August 7, 2024

Cadrenal Therapeutics and Abbott Initiate Collaborative Effort to Advance Novel Anticoagulant Tecarfarin for Patients with LVADs

PR Newswire August 6, 2024

Abbott Teams Up With the National Association of Community Health Centers to Expand Access to Nutritious Food and Improve Health

Accesswire July 30, 2024